Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 26, 2022

Impact of Renal Dysfunction on Cardiac Outcomes and ESRD in HF Patients With Mitral Regurgitation

European Heart Journal


Additional Info

European Heart Journal
Impact of baseline renal dysfunction on cardiac outcomes and end-stage renal disease in heart failure patients with mitral regurgitation: the COAPT trial
Eur Heart J 2022 Feb 03;[EPub Ahead of Print], N Beohar, G Ailawadi, LN Kotinkaduwa, B Redfors, M Simonato, Z Zhang, LG Morgan, E Escolar, S Kar, DS Lim, JM Mishell, BK Whisenant, WT Abraham, J Lindenfeld, MJ Mack, GW Stone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading